Reboxetine - Another new antidepressant

Drug and Therapeutics Bulletin

Volumn 36, Issue 11, 1998, Pages 86-88

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; DESIPRAMINE; REBOXETINE;

ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DRUG ABSORPTION; DRUG COST; HUMAN; HYPOTENSION; IMPOTENCE; INSOMNIA; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; SOCIAL INTERACTION; SWEATING; TACHYCARDIA; URINE RETENTION; XEROSTOMIA;

ADRENERGIC UPTAKE INHIBITORS; ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; MORPHOLINES; RANDOMIZED CONTROLLED TRIALS;

EID: 0031767558     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Dostert P, Benedetti MS, Poggesi I. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 1997; 7 (suppl 1): S23-35.
2. Ban TA, Gaszner P, Aguglia E et al. Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations. Hum Psychopharmacol 1998; 13 (suppl): S29-39.
3. Montgomery SA. Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 1997; 11 (suppl): S9-15.
4. Berzewski H, Van Moffaert M, Gagiano CA. Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes. Eur Neuropsychopharmacol 1997; 7 (suppl I): S37-47.
5. Massana J. Reboxetine (NARI) versus fluoxetine (SSRI): efficacy, tolerability and patient selection. Satellite symposium at the 6th World Congress of Biological Psychiatry (WCBP). 25th June 1997. In: Edronax (reboxetine). Information for Drugs and Therapeutics Committee. Milton Keynes: Pharmacia & Upjohn Ltd, 1997.
6. Dubini A, Bosc M, Pollin V. Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 1997; 7 (suppl 1): S49-55.
7. Bosc M, Dubini A, Polin V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol 1997; 7 (suppl 1): S57-70
8. Mucci M. Reboxetine: a review of antidepressant tolerability. J Psychopharmacol 1997; 11 (suppl): S33-7.
9. Kerr JS, Powell J, Hindmarch I. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 1996; 42: 239-41.